Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660—A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection - Concepedia

Concepedia

Publication | Open Access

Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660—A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection

DOI Full Paper Access

133

Citations

22

References

2018

Year

Erik R. Dubberke, Christine H. Lee, Robert Orenstein, Sahil Khanna, Gail Hecht, Dale N. Gerding

Clinical Infectious Diseases

Abstract

NCT02299570.

References

	Year	Citations

Page 1